Press releases
- Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
- Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
- Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
- Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
- Natera Reports First Quarter 2024 Financial Results
- New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
- Natera to Report its First Quarter 2024 Results on May 9
- Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
- Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
- Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
More ▼
Key statistics
As of last trade Natera Inc (45E:BER) traded at 103.00, 0.00% below its 52-week high of 103.00, set on Jun 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 103.00 |
---|---|
High | 103.00 |
Low | 103.00 |
Bid | 102.00 |
Offer | 103.00 |
Previous close | 103.00 |
Average volume | 33.67 |
---|---|
Shares outstanding | 122.80m |
Free float | 117.64m |
P/E (TTM) | -- |
Market cap | 13.65bn USD |
EPS (TTM) | -3.13 USD |
Data delayed at least 15 minutes, as of Jun 11 2024 07:02 BST.
More ▼